biote Corp.
BTMD
$1.47
-$0.02-1.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -9.48% | -8.28% | -6.87% | -6.67% | -0.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.48% | -8.28% | -6.87% | -6.67% | -0.62% |
| Cost of Revenue | 6.05% | 10.88% | 5.67% | -11.39% | -9.67% |
| Gross Profit | -15.63% | -14.92% | -11.79% | -4.68% | 3.49% |
| SG&A Expenses | 16.04% | 1.99% | -10.64% | 10.99% | -15.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.32% | 4.89% | -5.34% | 2.10% | -13.12% |
| Operating Income | -79.77% | -57.50% | -16.88% | -32.77% | 85.28% |
| Income Before Tax | -217.40% | -80.88% | 559.26% | -46.70% | 159.01% |
| Income Tax Expenses | -86.23% | -59.03% | 163.49% | -123.92% | 2,845.21% |
| Earnings from Continuing Operations | -289.25% | -83.10% | -24.86% | -27.19% | 137.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 216.89% | 81.19% | -401.36% | 47.42% | -122.55% |
| Net Income | -306.06% | -83.40% | -47.23% | -23.49% | 144.94% |
| EBIT | -79.77% | -57.50% | -16.88% | -32.77% | 85.28% |
| EBITDA | -74.31% | -53.43% | -15.22% | -29.73% | 79.74% |
| EPS Basic | -327.71% | -82.95% | -46.20% | -24.19% | 146.99% |
| Normalized Basic EPS | -77.47% | -54.57% | -64.58% | -19.95% | -11.70% |
| EPS Diluted | -330.00% | -83.78% | -36.62% | -33.33% | 146.66% |
| Normalized Diluted EPS | -77.40% | -54.63% | -58.00% | -28.98% | -12.00% |
| Average Basic Shares Outstanding | -9.48% | -2.67% | -1.87% | 0.92% | -4.37% |
| Average Diluted Shares Outstanding | -9.82% | -2.59% | -17.33% | 13.79% | -4.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -0.98% | -- |